A method of manufacturing artificial turf creating a liquid polymer mixture, wherein the polymer mixture is at least a two-phase system. A first one of the phases includes a first polymer and a first dye, and a second one of the phases of the polymer mixture includes a second polymer and a second dye. The second dye has a different color than the first dye, the second polymer being of the same or of a different type as the first polymer. The first and the second phase are immiscible, the first phase forming polymer beads within the second phase. The method further includes extruding the polymer mixture into a monofilament including a marbled pattern of the first and second color; quenching the monofilament; reheating the monofilament; stretching the reheated monofilament to deform the polymer beads into threadlike regions and to form the monofilament into an artificial turf fiber; and incorporating the artificial turf fiber into an artificial turf backing.

An electrospun nanofiber membrane and a method for preparing the electrospun nanofiber membrane are provided to solve problems of poor mechanical properties, short service life, poor uniformity and consistency of orientation of fibers and poor stability of fiber networks in current electrospun composite nanofiber materials. The electrospun nanofiber membrane is prepared by spinning solution through a high-voltage electrospinning device. The spinning solution is blending solution of regenerated silk fibroin: polyvinyl alcohol: polylactic acid with a mass ratio being 75-85:10-20:5 dissolved in a mixed solvent of trifluoroacetic acid and dichloromethane with a volume ratio being 7:3. The method establishes a reasonable mass ratio parameter of the regenerated silk fibroin, the polyvinyl alcohol and the polylactic acid to blending spinning to improve spinnability of silk fibroin, as well as prepare the electrospun composite nanofiber membrane with good mechanical properties.

The present disclosure provides a fabric, a preparation method thereof and clothing formed therefrom. The preparation method includes the following steps: obtaining bio-based synthetic fiber chips from textile waste materials; obtaining extruded filaments from the bio-based synthetic fiber chips by adopting a spinning solution; and weaving and interlocking the extruded filaments with bio-based elastic fibers to obtain the fabric. The prepared fabric is obtained from the textile waste materials, so that waste recycling is realized, and the pollution of the textile wastes to the environment is avoided. The spinning solution is adopted in the preparation process of the fabric, so that the opacity and hydrophilicity of the fabric can be enhanced.

An infrared-absorbent resin composition including a tungsten-based infrared-absorbent pigment, copolymerized polyethylene terephthalate, and a polyethylene terephthalate homopolymer, wherein the copolymerized polyethylene terephthalate is crystalline.

An infrared-absorbent resin composition including a tungsten-based infrared-absorbent pigment, copolymerized polyethylene terephthalate, and a polyethylene terephthalate homopolymer, wherein the copolymerized polyethylene terephthalate is crystalline.

A medical sheet has a cell infiltration suppressing action, including a nonwoven fabric formed of fiber containing an aliphatic polyester, and having a porosity of 50 to 90%. The sheet is very useful because it has an excellent neuroprotective and/or nerve regeneration promoting action, which protects nerves by suppressing the infiltration of inflammatory cells such as macrophages and not giving stimulation that adversely affects nerves because body fluids pass therethrough, by winding around a nerve at a peripheral nerve injury site.

A medical sheet has a cell infiltration suppressing action, including a nonwoven fabric formed of fiber containing an aliphatic polyester, and having a porosity of 50 to 90%. The sheet is very useful because it has an excellent neuroprotective and/or nerve regeneration promoting action, which protects nerves by suppressing the infiltration of inflammatory cells such as macrophages and not giving stimulation that adversely affects nerves because body fluids pass therethrough, by winding around a nerve at a peripheral nerve injury site.

The present invention provides a medical dressing article and a method of manufacturing the same, which comprises: (a) a first layer comprised of polycaprocaptone fibers having a PCL fiber diameter of 0.5 μm and 2.9 μm; (b) a second layer, deposited directly on the first layer, including a mixture of polycaprolactone and poloxamer fibers (PCL and POX fibers) wherein a PCL and POX fiber diameter is between 0.1 μm and 4 μm; and (c) a third layer, deposited directly on the second layer, further comprising a mixture of gelatin and silver nitrate (AgNO.sub.3).

An electrospun nanofiber membrane and a method for preparing the electrospun nanofiber membrane are provided to solve problems of poor mechanical properties, short service life, poor uniformity and consistency of orientation of fibers and poor stability of fiber networks in current electrospun composite nanofiber materials. The electrospun nanofiber membrane is prepared by spinning solution through a high-voltage electrospinning device. The spinning solution is blending solution of regenerated silk fibroin:polyvinyl alcohol:polylactic acid with a mass ratio being 75-85:10-20:5 dissolved in a mixed solvent of trifluoroacetic acid and dichloromethane with a volume ratio being 7:3. The method establishes a reasonable mass ratio parameter of the regenerated silk fibroin, the polyvinyl alcohol and the polylactic acid to blending spinning to improve spinnability of silk fibroin, as well as prepare the electrospun composite nanofiber membrane with good mechanical properties.

A filament or printing material placed in a syringe for 3D printing comprising polymers, proteins, and/or functional particles and materials is provided. Methods of treating a bone defect in a subject in need thereof comprising using a handheld 3D printer to apply a filament or the printing material placed in a syringe to the bone defect of the subject are also provided. Methods of fixing or gluing natural or synthetic bone grafts using a handheld 3D printer to apply a filament or the printing material placed in a syringe over and around the defect or at the interface of a flap and the bone. Methods of printing a graft cage for retaining bone grafts and/or bone graft substitute in its desired location during healing for treatment of critical-sized segmental defects in long bones are provided.